Alternating combination chemotherapy in patients with extragonadal germ cell tumors a southwest oncology group study

R. Bukowski,M. Wolf,B. Kulander,J. Montie,E. Crawford,B. Blumenstein
DOI: https://doi.org/10.1002/1097-0142(19930415)71:8<2631::AID-CNCR2820710831>3.0.CO;2-G
IF: 6.9209
1993-04-15
Cancer
Abstract:Background. Extragonadal germ cell tumors (EGGCT) are uncommon, occur primarily in the mediastinum and retroperitoneum, and have been noted to have variable response rates to cisplatin‐based chemotherapy regimens.
What problem does this paper attempt to address?